Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax Provisions
Others
Ratios

GeneDx Holdings (WGS) Cost of Revenue: 2020-2025

Historic Cost of Revenue for GeneDx Holdings (WGS) over the last 6 years, with Sep 2025 value amounting to $32.2 million.

  • GeneDx Holdings' Cost of Revenue rose 10.92% to $32.2 million in Q3 2025 from the same period last year, while for Sep 2025 it was $122.1 million, marking a year-over-year increase of 12.74%. This contributed to the annual value of $111.1 million for FY2024, which is 1.34% down from last year.
  • Latest data reveals that GeneDx Holdings reported Cost of Revenue of $32.2 million as of Q3 2025, which was up 1.34% from $31.8 million recorded in Q2 2025.
  • In the past 5 years, GeneDx Holdings' Cost of Revenue ranged from a high of $77.7 million in Q4 2022 and a low of $25.0 million during Q1 2024.
  • Over the past 3 years, GeneDx Holdings' median Cost of Revenue value was $28.6 million (recorded in 2025), while the average stood at $28.8 million.
  • As far as peak fluctuations go, GeneDx Holdings' Cost of Revenue surged by 51.33% in 2021, and later plummeted by 65.67% in 2023.
  • Over the past 5 years, GeneDx Holdings' Cost of Revenue (Quarterly) stood at $60.6 million in 2021, then rose by 28.16% to $77.7 million in 2022, then plummeted by 65.67% to $26.7 million in 2023, then climbed by 10.39% to $29.4 million in 2024, then grew by 10.92% to $32.2 million in 2025.
  • Its last three reported values are $32.2 million in Q3 2025, $31.8 million for Q2 2025, and $28.6 million during Q1 2025.